Pharmaceuticals in the United States
SummaryPharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The US pharmaceuticals market had total revenues of $397.0 billion in 2021, representing a compound annual growth rate (CAGR) of 4.3% between 2016 and 2021.
- The US government continued to invest heavily in pharmaceutical companies in 2021 to accelerate the development, manufacture, and procurement of COVID-19 vaccines and therapeutics. This has resulted in stable growth of the pharmaceuticals market.
- New policies by the US government to reduce the pricing of medications and build an affordable healthcare system could contribute to a slowdown in market growth. As healthcare becomes more affordable and accessible, the ability of pharmaceutical companies to freely set prices will become limited.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the United States
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts
Reasons To Buy
- What was the size of the United States pharmaceuticals market by value in 2021?
- What will be the size of the United States pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the United States pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up the United State's pharmaceuticals market?
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.